Alafair Biosciences, Inc.

Alafair Biosciences develops and manufactures naturally-derived biopolymer surgical protection technologies designed to prevent postsurgical soft-tissue tethering and adhesion formation. The company specializes in hydrogel-based protective barriers composed of hyaluronic acid and alginate that create a permeable, conformable gliding surface between target tissues and surrounding structures during surgery. This technology reduces scarring, maintains independent tissue movement, minimizes pain, and lowers revision surgery rates. Primary product: VersaWrap Hydrogel Sheet, available in Tendon Protector and Nerve Protector configurations. VersaWrap is FDA-cleared and bioresorbable, designed for use in orthopedic, hand surgery, and soft-tissue procedures. The company has achieved significant clinical adoption with over 22,000 implants deployed. Alafair serves hospitals, surgical centers, and surgeon practices across the US. The company has received recognition including Inc. 5000 status (three appearances), female founders recognition, and innovative technology contracts from major healthcare networks including Vizient. Manufacturing and distribution capabilities support broad hospital and surgical facility reach.